Guasch A, Deen W M, Myers B D
Nephrology Division, Stanford University Medical Center, California 94305.
J Clin Invest. 1993 Nov;92(5):2274-82. doi: 10.1172/JCI116831.
We used dextran sulfate (DS) to evaluate barrier charge selectivity in 11 nonproteinuric subjects and in 11 patients with the nephrotic syndrome due to either membranous nephropathy or minimal change nephropathy. The 3H-DS preparation spanned a molecular radius interval of 10-24 A and exhibited size-dependent protein binding in vitro. Urine and ultrafiltrates of plasma were separated by size into narrow fractions using gel permeation chromatography. The sieving coefficient (theta) for ultrafilterable DS of 15A radius averaged 0.68 +/- 0.03 in nonproteinuric vs. 0.95 +/- 0.05 in nephrotic subjects (P < 0.001). Uncharged dextrans of broad size distribution were used to evaluate barrier size-selectivity in separate groups of nonproteinuric subjects (n = 19) and nephrotic patients with either minimal change (n = 20) or membranous nephropathy (n = 27). The value of theta for an uncharged dextran of similarly small radius (approximately 18 A) was significantly larger than that observed for DS in nonproteinuric subjects, but was similar in nephrotic individuals. Further, impaired barrier size-selectivity, as assessed by the sieving profile for uncharged dextrans (18-60 A radius), failed to account fully for the observed level of albuminuria in almost half of the patients with either minimal change (9/20) or membranous nephropathy (12/27). Together these findings suggest that the human glomerular capillary wall normally provides an electrostatic barrier to filtration of negatively charged macromolecules such as albumin, and that impairment of this electrostatic barrier contributes to the magnitude of albuminuria in the nephrotic syndrome.
我们使用硫酸葡聚糖(DS)评估了11名非蛋白尿患者以及11名因膜性肾病或微小病变肾病导致肾病综合征的患者的屏障电荷选择性。3H-DS制剂的分子半径范围为10 - 24 Å,且在体外表现出与大小相关的蛋白质结合特性。使用凝胶渗透色谱法按大小将尿液和血浆超滤液分离成狭窄的组分。半径为15 Å的可超滤DS的筛分系数(θ)在非蛋白尿患者中平均为0.68±0.03,而在肾病患者中为0.95±0.05(P < 0.001)。使用大小分布广泛的不带电荷的葡聚糖评估了单独分组的非蛋白尿患者(n = 19)以及患有微小病变(n = 20)或膜性肾病(n = 27)的肾病患者的屏障大小选择性。对于半径类似小(约18 Å)的不带电荷的葡聚糖,其θ值在非蛋白尿患者中显著大于DS的观察值,但在肾病个体中相似。此外,通过不带电荷的葡聚糖(半径18 - 60 Å)的筛分曲线评估的屏障大小选择性受损,在几乎一半的微小病变患者(9/20)或膜性肾病患者(12/27)中未能完全解释观察到的蛋白尿水平。这些发现共同表明,人类肾小球毛细血管壁通常为诸如白蛋白等带负电荷的大分子过滤提供静电屏障,并且这种静电屏障的损害导致了肾病综合征中蛋白尿的程度。